Board of Scientific Counselors, Coordinating Center for Health Promotion (BSC, CCHP), 27805 [E9-13692]

Download as PDF Federal Register / Vol. 74, No. 111 / Thursday, June 11, 2009 / Notices This notice is corrected as follows: On page 26704 first column, under SUMMARY, the Web site should read: https://wwwn.cdc.gov/publiccomments/. Dated: June 4, 2009. James D. Seligman, Chief Information Officer, Centers for Disease Control and Prevention. [FR Doc. E9–13694 Filed 6–10–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. jlentini on PROD1PC65 with NOTICES Name of Committee: National Institute of General Medical Sciences; Initial Review Group Minority Programs Review, Subcommittee B. Date: July 9–10, 2009. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 20814. Contact Person: Rebecca H. Johnson, PhD, Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, Natcher Building, Room 3AN18C, Bethesda, MD 20892. 301–594–2771. Johnsonrhnigms.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS) 27805 DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Centers for Disease Control and Prevention National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; MBRS SCORE. Date: July 9, 2009. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, Room 3AN12, 45 Center Drive, Bethesda, MD 20892 (Telephone Conference Call) Contact Person: Arthur L. Zachary, PhD, Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, Natcher Building, Room 3AN–12, Bethesda, MD 20892, (301) 594–2886, zacharya@nigms.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS) Dated: June 4, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–13758 Filed 6–10–09; 8:45 am] BILLING CODE 4140–01–M Board of Scientific Counselors, Coordinating Center for Health Promotion (BSC, CCHP) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: Time and Date: 8:30 a.m.–5 p.m., July 1, 2009. Place: CDC, 1825 Century Boulevard, NE., Room 1042, Atlanta, Georgia 30345. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 75 people. Purpose: This BSC is charged with providing advice and guidance to the Secretary of Health and Human Services, the Director of CDC, and the Director of CCHP concerning strategies and goals for the programs and research within the National Center on Birth Defects and Developmental Disabilities and the National Center for Chronic Disease Prevention and Health Promotion. Matters To Be Discussed: The agenda will include a review and discussion of charges to the BSC Work Groups. The Work Group projects include strategic planning and procedures for future external peer review of programs in the National Center on Birth Defects and Developmental Disabilities, and the National Center for Chronic Disease Prevention and Health Promotion. The BSC will also discuss results of its review of the National Center for Chronic Disease Prevention and Health Promotion as an organizational unit at CDC. Providing Oral or Written Comments: It is the policy of the BSC, CCHP to provide a brief period for oral public comments. In general, each individual or group requesting to make an oral presentation will be limited to a total time of five minutes if time permits. Contact Person for Additional Information: Karen Steinberg, PhD, Senior Science Officer, Coordinating Center for Health Promotion, CDC, 4770 Buford Highway, NE., Mailstop E– 70, Atlanta, Georgia 30341; telephone (404) 498–6700; fax (404) 498–6880; or via e-mail at Karen.Steinberg@cdc.hhs.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 4, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–13757 Filed 6–10–09; 8:45 am] Dated: June 4, 2009. Lorenzo Falgiano, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–13692 Filed 6–10–09; 8:45 am] BILLING CODE 4140–01–M BILLING CODE 4163–18–P VerDate Nov<24>2008 16:37 Jun 10, 2009 Jkt 217001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\11JNN1.SGM 11JNN1

Agencies

[Federal Register Volume 74, Number 111 (Thursday, June 11, 2009)]
[Notices]
[Page 27805]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-13692]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Coordinating Center for Health 
Promotion (BSC, CCHP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:

    Time and Date: 8:30 a.m.-5 p.m., July 1, 2009.
    Place: CDC, 1825 Century Boulevard, NE., Room 1042, Atlanta, 
Georgia 30345.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 75 people.
    Purpose: This BSC is charged with providing advice and guidance 
to the Secretary of Health and Human Services, the Director of CDC, 
and the Director of CCHP concerning strategies and goals for the 
programs and research within the National Center on Birth Defects 
and Developmental Disabilities and the National Center for Chronic 
Disease Prevention and Health Promotion.
    Matters To Be Discussed: The agenda will include a review and 
discussion of charges to the BSC Work Groups. The Work Group 
projects include strategic planning and procedures for future 
external peer review of programs in the National Center on Birth 
Defects and Developmental Disabilities, and the National Center for 
Chronic Disease Prevention and Health Promotion. The BSC will also 
discuss results of its review of the National Center for Chronic 
Disease Prevention and Health Promotion as an organizational unit at 
CDC.
    Providing Oral or Written Comments: It is the policy of the BSC, 
CCHP to provide a brief period for oral public comments. In general, 
each individual or group requesting to make an oral presentation 
will be limited to a total time of five minutes if time permits.
    Contact Person for Additional Information: Karen Steinberg, PhD, 
Senior Science Officer, Coordinating Center for Health Promotion, 
CDC, 4770 Buford Highway, NE., Mailstop E-70, Atlanta, Georgia 
30341; telephone (404) 498-6700; fax (404) 498-6880; or via e-mail 
at Karen.Steinberg@cdc.hhs.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for CDC and the Agency for Toxic Substances and Disease 
Registry.

    Dated: June 4, 2009.
Lorenzo Falgiano,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E9-13692 Filed 6-10-09; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.